Nuvation Bio, Inc. (NUVB)
4.45
-0.30
(-6.32%)
USD |
NYSE |
Oct 16, 16:00
4.46
+0.01
(+0.22%)
After-Hours: 20:00
Nuvation Bio Free Cash Flow (Quarterly) : -43.22M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -43.22M |
| March 31, 2026 | 5.021M |
| December 31, 2025 | -29.82M |
| September 30, 2025 | -60.90M |
| June 30, 2025 | -48.36M |
| March 31, 2025 | -42.70M |
| December 31, 2024 | -46.29M |
| September 30, 2024 | -31.23M |
| June 30, 2024 | -37.32M |
| March 31, 2024 | -15.73M |
| December 31, 2023 | -15.04M |
| September 30, 2023 | -16.18M |
| June 30, 2023 | -17.51M |
| Date | Value |
|---|---|
| March 31, 2023 | -19.34M |
| December 31, 2022 | -16.23M |
| September 30, 2022 | -28.20M |
| June 30, 2022 | -27.11M |
| March 31, 2022 | -24.94M |
| December 31, 2021 | -23.62M |
| September 30, 2021 | -13.18M |
| June 30, 2021 | -16.83M |
| March 31, 2021 | -14.84M |
| December 31, 2020 | -12.96M |
| September 30, 2020 | -8.053M |
| June 30, 2020 | -6.842M |
| March 31, 2020 | -8.815M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 3.088B |
| Johnson & Johnson | 7.295B |
| Pfizer Inc. | 302.00M |
| Eli Lilly & Co. | 4.475B |
| Merck & Co., Inc. | 4.477B |